Labcorp (LH) CEO Adam Schechter sells 4,669 shares at $320.37 under 10b5-1 plan

Rhea-AI Filing Summary

LABCORP HOLDINGS INC. President & CEO Adam H. Schechter reported a sale of common stock. On 2026-08-11, he sold 4,669 shares of Labcorp common stock at a price of $320.37 per share in an open-market or private transaction. After this transaction, he directly holds 102,565 shares of common stock. The sale was executed pursuant to a pre-established trading plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

Insider Trade Summary 10b5-1

Net Seller: 4,669 shares

Net Sell 1 txn

Insider Schechter Adam H

Role President & CEO

Sold 4,669 shs ($1.50M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	4,669	$320.37	$1.50M

Holdings After Transaction: Common Stock — 102,565 shares (Direct)

Footnotes (1)

1. F1. Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Key Figures

Shares sold: 4,669 shares Sale price per share: $320.37 per share Shares held after transaction: 102,565 shares

3 metrics

Shares sold 4,669 shares Common stock sale reported for 2026-08-11

Sale price per share $320.37 per share Price for the 4,669 Labcorp common shares sold

Shares held after transaction 102,565 shares Direct Labcorp common stock holdings after the sale

Key Terms

Rule 10b5-1, open market or private transaction, common stock

3 terms

Rule 10b5-1 regulatory

"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

open market or private transaction financial

"transaction code description: Sale in open market or private transaction"

common stock financial

"security_title: Common Stock for the reported sale transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/12/2026 - 02:31 PM Accepted by SEC EDGAR 08/12/2026 - 02:31 PM Learn about SEC filing dates

FAQ

What did Labcorp (LH) CEO Adam H. Schechter report in this Form 4?

Adam H. Schechter reported a sale of 4,669 Labcorp common shares at $320.37 per share on 2026-08-11. Following the transaction, he directly holds 102,565 shares of Labcorp common stock.

At what price did the Labcorp (LH) CEO sell his shares?

The reported sale by Labcorp CEO Adam H. Schechter was executed at $320.37 per share. This price applies to the 4,669 common shares sold on 2026-08-11 in an open-market or private transaction.

How many Labcorp (LH) shares does the CEO hold after this transaction?

After the reported sale, Adam H. Schechter directly holds 102,565 Labcorp common shares. This figure reflects his direct ownership position immediately following the 4,669-share sale on 2026-08-11.

Was the Labcorp (LH) CEO’s share sale under a Rule 10b5-1 trading plan?

Yes. The filing states the transaction was made pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, indicating it was executed under a pre-established trading arrangement.

What type of transaction did Labcorp (LH) report for its CEO in this Form 4?

The Form 4 reports a sale transaction of Labcorp common stock by CEO Adam H. Schechter. The transaction code is “S”, described as a sale in an open market or private transaction, covering 4,669 shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schechter Adam H

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NORTH CAROLINA 27215

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/11/2026		S(1)		4,669	D	$320.37	102,565	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Adam H. Schechter	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)